Medifast, Inc.
MED
$11.48
$0.000.00%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.45% | 1.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.45% | 1.26% | |||
| Cost of Revenue | -5.35% | 5.80% | |||
| Gross Profit | 3.17% | -0.74% | |||
| SG&A Expenses | 2.83% | -4.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.00% | -1.66% | |||
| Operating Income | 21.03% | 29.78% | |||
| Income Before Tax | -54.10% | 69.59% | |||
| Income Tax Expenses | -39.78% | -98.46% | |||
| Earnings from Continuing Operations | -46.09% | 88.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -46.09% | 88.29% | |||
| EBIT | 21.03% | 29.78% | |||
| EBITDA | 55.86% | 53.99% | |||
| EPS Basic | -44.40% | 88.30% | |||
| Normalized Basic EPS | 27.60% | 36.10% | |||
| EPS Diluted | -45.23% | 88.30% | |||
| Normalized Diluted EPS | 27.60% | 36.10% | |||
| Average Basic Shares Outstanding | 1.17% | 0.14% | |||
| Average Diluted Shares Outstanding | 1.17% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.35% | -- | |||